LPCN logo

Lipocine (LPCN) Current Liabilities

LPCN Annual Current Liabilities

$2.63 M
+$953.50 K+56.82%

31 December 2023

LPCN Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LPCN Quarterly Current Liabilities

$1.58 M
-$242.70 K-13.31%

30 September 2024

LPCN Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LPCN Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+56.8%-39.9%
3 y3 years-60.0%-13.5%
5 y5 years-41.4%-13.5%

LPCN Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.1%+56.8%-71.8%+6.1%
5 y5-year-60.0%+56.8%-82.0%+6.1%
alltimeall time-60.0%>+9999.0%-82.0%>+9999.0%

Lipocine Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$1.58 M(-13.3%)
June 2024
-
$1.82 M(+22.4%)
Mar 2024
-
$1.49 M(-43.4%)
Dec 2023
$2.63 M(+56.8%)
$2.63 M(+17.4%)
Sept 2023
-
$2.24 M(+22.7%)
June 2023
-
$1.83 M(-5.3%)
Mar 2023
-
$1.93 M(+15.0%)
Dec 2022
$1.68 M(-70.1%)
$1.68 M(+11.0%)
Sept 2022
-
$1.51 M(-11.8%)
June 2022
-
$1.71 M(-51.3%)
Mar 2022
-
$3.52 M(-37.3%)
Dec 2021
$5.62 M(-14.7%)
$5.62 M(-12.7%)
Sept 2021
-
$6.43 M(-27.0%)
June 2021
-
$8.81 M(+63.2%)
Mar 2021
-
$5.40 M(-18.0%)
Dec 2020
$6.58 M(+32.6%)
$6.58 M(+13.7%)
Sept 2020
-
$5.79 M(+36.8%)
June 2020
-
$4.23 M(+4.2%)
Mar 2020
-
$4.06 M(-18.2%)
Dec 2019
$4.96 M(+10.5%)
$4.96 M(-5.2%)
Sept 2019
-
$5.23 M(+17.8%)
June 2019
-
$4.44 M(+3.9%)
Mar 2019
-
$4.28 M(-4.8%)
Dec 2018
$4.49 M
$4.49 M(+46.3%)
Sept 2018
-
$3.07 M(+8.0%)
June 2018
-
$2.84 M(-54.8%)
DateAnnualQuarterly
Mar 2018
-
$6.28 M(-1.0%)
Dec 2017
$6.35 M(+378.4%)
$6.35 M(+155.4%)
Sept 2017
-
$2.48 M(-14.3%)
June 2017
-
$2.90 M(+23.7%)
Mar 2017
-
$2.35 M(+76.8%)
Dec 2016
$1.33 M(-60.9%)
$1.33 M(-15.6%)
Sept 2016
-
$1.57 M(-39.2%)
June 2016
-
$2.58 M(-13.7%)
Mar 2016
-
$2.99 M(-11.7%)
Dec 2015
$3.39 M(+107.6%)
$3.39 M(+55.7%)
Sept 2015
-
$2.18 M(+30.9%)
June 2015
-
$1.67 M(+24.5%)
Mar 2015
-
$1.34 M(-18.1%)
Dec 2014
$1.63 M(+27.2%)
$1.63 M(-20.6%)
Sept 2014
-
$2.06 M(+23.1%)
June 2014
-
$1.67 M(+11.4%)
Mar 2014
-
$1.50 M(+16.8%)
Dec 2013
$1.28 M(>+9900.0%)
$1.28 M(-21.2%)
Sept 2013
-
$1.63 M(+9151.7%)
June 2013
-
$17.60 K(+17.3%)
Mar 2013
-
$15.00 K(+26.1%)
Dec 2012
$11.90 K(+56.6%)
$11.90 K(+70.0%)
Sept 2012
-
$7000.00(+70.7%)
June 2012
-
$4100.00(-44.6%)
Mar 2012
-
$7400.00
Dec 2011
$7600.00
-

FAQ

  • What is Lipocine annual total current liabilities?
  • What is the all time high annual current liabilities for Lipocine?
  • What is Lipocine annual current liabilities year-on-year change?
  • What is Lipocine quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Lipocine?
  • What is Lipocine quarterly current liabilities year-on-year change?

What is Lipocine annual total current liabilities?

The current annual current liabilities of LPCN is $2.63 M

What is the all time high annual current liabilities for Lipocine?

Lipocine all-time high annual total current liabilities is $6.58 M

What is Lipocine annual current liabilities year-on-year change?

Over the past year, LPCN annual total current liabilities has changed by +$953.50 K (+56.82%)

What is Lipocine quarterly total current liabilities?

The current quarterly current liabilities of LPCN is $1.58 M

What is the all time high quarterly current liabilities for Lipocine?

Lipocine all-time high quarterly total current liabilities is $8.81 M

What is Lipocine quarterly current liabilities year-on-year change?

Over the past year, LPCN quarterly total current liabilities has changed by -$1.05 M (-39.91%)